GlassScriptPhysician profile
Cortney Muldoon
NPI 1912455809
$1,191.90
in general payments reported to CMS, 2019-2025
17 companies · $341 in 2025
The $341 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $22.97 · 2022: $148 · 2023: $209 · 2024: $472 · 2025: $341.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,021.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,021.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $257.48 | 2024-2025 | Korlym |
| Exact Sciences Corporation | $167.28 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Teva Pharmaceuticals USA, INC. | $122.87 | 2022-2025 | Austedo Xr, Uzedy, Austedo Xr |
| Lilly USA, LLC | $108.35 | 2022-2024 | Mounjaro, Zepbound, Emgality |
| Abbvie INC. | $90.70 | 2024 | |
| Verona Pharma, INC. | $79.25 | 2025 | Ohtuvayre |
| Pfizer INC. | $78.28 | 2023-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $67.48 | 2022-2023 | Synjardy, Jardiance |
| Sanofi-Aventis U.S. LLC | $37.00 | 2024 | |
| Vanda Pharmaceuticals INC. | $31.19 | 2025 | Fanapt |
| Bayer Healthcare Pharmaceuticals INC. | $27.42 | 2024 | |
| Corium, LLC | $24.03 | 2023 | Azstarys |
| Glaxosmithkline, LLC. | $22.97 | 2021 | |
| Novartis Pharmaceuticals Corporation | $21.26 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $20.81 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $19.71 | 2022 | |
| Novo Nordisk INC | $15.82 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cortney Muldoon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.